The role of progesterone elevation in IVF.

Embryo quality Endometrial receptivity Implantation In vitro fertilization Progesterone elevation

Journal

Reproductive biology
ISSN: 2300-732X
Titre abrégé: Reprod Biol
Pays: Poland
ID NLM: 101160559

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 31 12 2018
revised: 04 02 2019
accepted: 07 02 2019
pubmed: 20 2 2019
medline: 5 9 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

Elevation of progesterone during the late follicular phase of stimulated in-vitro fertilization cycles is a frequent event, which negatively impacts the outcome. Over the years evidence has demonstrated a direct relationship between late-follicular elevated progesterone and endometrial receptivity. In this regard, elective cryopreservation of all good quality embryos and transfer in a subsequent frozen/thawed cycle is the most common strategy adopted by clinicians in case of elevated progesterone. Nonetheless, recent evidence suggests that elective cryopreservation might not entirely resolve the reduced pregnancy outcomes associated with the elevation of progesterone, considering that the increase may affect not only implantation, but also embryo quality.

Identifiants

pubmed: 30777675
pii: S1642-431X(18)30435-2
doi: 10.1016/j.repbio.2019.02.003
pii:
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-5

Informations de copyright

Copyright © 2019 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn. Published by Elsevier B.V. All rights reserved.

Auteurs

Panagiotis Drakopoulos (P)

Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium; Faculty of Medicine and Pharmacy, Department of Surgical and Clinical Science, Vrije Universiteit Brussel, Belgium. Electronic address: panagiotisdrakopoulos@hotmail.com.

Annalisa Racca (A)

Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium; University of Genoa, Academic Unit of Obstetrics and Gynecology, IRCCS AOU San Martino, Italy.

Joaquín Errázuriz (J)

Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium; Centre for Reproductive Medicine, Clínica Alemana, Santiago, Chile.

Michel De Vos (M)

Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium; Faculty of Medicine and Pharmacy, Department of Surgical and Clinical Science, Vrije Universiteit Brussel, Belgium.

Herman Tournaye (H)

Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Christophe Blockeel (C)

Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium; Faculty of Medicine and Pharmacy, Department of Surgical and Clinical Science, Vrije Universiteit Brussel, Belgium; University of Zagreb-School of Medicine, Department of Obstetrics and Gynecology, Zagreb, Croatia.

Nicola Pluchino (N)

Division of Obstetrics and Gynecology, University Hospital of Geneva, Geneva, Switzerland.

Samuel Santos-Ribeiro (S)

Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium; Faculty of Medicine and Pharmacy, Department of Surgical and Clinical Science, Vrije Universiteit Brussel, Belgium; IVI-RMA, Lisbon, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH